Diabetes Care 24:1674-1678, 2001
© 2001 by the American Diabetes Association, Inc.
Pathophysiology/Complications Original Article |
Endothelial Perturbation in Children and Adolescents With Type 1 Diabetes
Association with markers of the inflammatory reaction
Mario Romano, MD1,
Mariapina Pomilio, MD2,
Sergio Vigneri, MD3,
Angela Falco, MD4,
Pierluigi Lelli Chiesa, MD5,
Francesco Chiarelli, MD2 and
Giovanni Davì, MD4
1 Department of Human Pathology, University of Messina, Messina
2 Department of Medicine and Aging, Division of Pediatrics, University of Chieti, Chieti
3 Department of Medicine, University of Palermo, Palermo
4 Department of Medicine and Aging, Division of Hematology, University of Chieti, Chieti
5 the Department of Medicine and Aging, Division of Pediatric Surgery, University of Chieti, Chieti, Italy
OBJECTIVEThe progression of diabetic angiopathy is, in most cases, unpredictable. The aim of this study was to investigate early events that could influence the development of diabetic angiopathy.
RESEARCH DESIGN AND METHODSCirculating levels of von Willebrand factor (vWF) and tissue-plasminogen activator (tPA), defining endothelial perturbation, were measured in 40 young patients with type 1 diabetes. Patients were divided into two groups according to the duration of diabetes (group A, <1 year; group B, >1 year) and compared with a control group of age- and sex-matched healthy individuals. Prothrombin fragment 1 and 2 (F1+2), tumor necrosis factor- (TNF- ), and C-reactive protein (CRP) levels were also determined as markers of a prothrombotic state and inflammatory response. A total of 16 of the 20 children in group A were re-examined after 12 months.
RESULTSCompared with either normal subjects or patients in group B, children in group A showed increased levels of vWF, tPA, F1+2, TNF- , and CRP. Significant direct correlations between TNF- or CRP and either vWF, tPA, or F1+2 were observed. Endothelial perturbation was shown in 70% of group A and 20% of group B. After 1 year, 16 of the 20 patients in group A showed a significant reduction in vWF, tPA, F1+2, TNF- , and CRP levels, whereas endothelial perturbation was reversed in 5 of these patients.
CONCLUSIONSEndothelial perturbation represents an early and, in some cases, reversible event in the chronology of type 1 diabetes in children. A correlation might exist between the initial inflammatory reaction and the appearance of endothelial perturbation.
Abbreviations: CRP, C-reactive protein ELISA, enzyme-linked immunosorbent assay F1+2, prothrombin fragment 1 and 2 ICA-IgG, anti-islet cell antibodies IL-1ß, interleukin-1ß IL-6, interleukin-6 TNF- , tumor necrosis factor- tPA, tissue-plasminogen activator vWF, von Willebrand factor

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. F. Lopes-Virella, R. E. Carter, G. E. Gilbert, R. L. Klein, M. Jaffa, A. J. Jenkins, T. J. Lyons, W. T. Garvey, G. Virella, and and the DCCT/EDIC Cohort Study Group
Risk Factors Related to Inflammation and Endothelial Dysfunction in the DCCT/EDIC Cohort and Their Relationship With Nephropathy and Macrovascular Complications
Diabetes Care,
October 1, 2008;
31(10):
2006 - 2012.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Kwon, S.-M. Hong, T. A. Sutton, and C. J. Temm
Preservation of peritubular capillary endothelial integrity and increasing pericytes may be critical to recovery from postischemic acute kidney injury
Am J Physiol Renal Physiol,
August 1, 2008;
295(2):
F351 - F359.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-W. Xu, I. Morita, K. Ikeda, T. Miki, and Y. Yamori
C-Reactive Protein Suppresses Insulin Signaling in Endothelial Cells: Role of Spleen Tyrosine Kinase
Mol. Endocrinol.,
February 1, 2007;
21(2):
564 - 573.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. O. Schwab, J. Doerfer, W. Hecker, J. Grulich-Henn, D. Wiemann, O. Kordonouri, P. Beyer, R. W. Holl, and on behalf of the DPV Initiative of the German Work
Spectrum and Prevalence of Atherogenic Risk Factors in 27,358 Children, Adolescents, and Young Adults With Type 1 Diabetes: Cross-sectional data from the German diabetes documentation and quality management system (DPV)
Diabetes Care,
February 1, 2006;
29(2):
218 - 225.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Chiarelli, D. Di Marzio, F. Santilli, A. Mohn, A. Blasetti, F. Cipollone, A. Mezzetti, and A. Verrotti
Effects of Irbesartan on Intracellular Antioxidant Enzyme Expression and Activity in Adolescents and Young Adults With Early Diabetic Angiopathy
Diabetes Care,
July 1, 2005;
28(7):
1690 - 1697.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. R. Dalton, W. H. Hoffman, G. G. Passmore, and S. L. A. Martin
Plasma C-Reactive Protein Levels in Severe Diabetic Ketoacidosis
Ann. Clin. Lab. Sci.,
October 1, 2003;
33(4):
435 - 442.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. R. Golomb, M. Rafay, D. Armstrong, P. Massicotte, R. Curtis, S. Hune, and G. A. deVeber
Intra-arterial Tissue Plasminogen Activator for Thrombosis Complicating Cerebral Angiography in a 17-Year-Old Girl
J Child Neurol,
June 1, 2003;
18(6):
420 - 423.
[Abstract]
[PDF]
|
 |
|
Copyright © 2001 by the American Diabetes Association.
|
|
| |
|